Drugs & TargetsFree Roswell Park selects Circuit Clinical as collaborator for CIMAvax clinical trial April 19, 2019Vol.45 No.16
Drugs & Targets FDA expands pembrolizumab indication for first-line treatment of NSCLC April 12, 2019Vol.45 No.15
Drugs & Targets American Cancer Society study shows need to better identify who may not benefit from aggressive treatment April 12, 2019Vol.45 No.15
Drugs & TargetsFree Varian ARIA Oncology Information System awarded CancerLinQ certification April 05, 2019Vol.45 No.14
Drugs & TargetsFree FDA expands use of metastatic breast cancer treatment to include male patients April 05, 2019Vol.45 No.14
Drugs & TargetsFree FDA issues warning letter to genomics lab for marketing genetic test that claims to predict patients’ responses to specific medications April 05, 2019Vol.45 No.14
Drugs & TargetsFree Nanobiotix receives European approval for Hensify therapy for sarcoma April 05, 2019Vol.45 No.14
